Document is current
Any future updates will be listed below
-
Authors
Kightlinger, Weston https://orcid.org/0000-0002-5264-4866
Duncker, Katherine E. https://orcid.org/0000-0003-4585-5507
Ramesh, Ashvita https://orcid.org/0000-0002-6468-0709
Thames, Ariel H. https://orcid.org/0000-0001-5418-6048
Natarajan, Aravind https://orcid.org/0000-0003-2180-7842
Stark, Jessica C. https://orcid.org/0000-0003-3828-5438
Yang, Allen
Lin, Liang https://orcid.org/0000-0001-6517-769X
Mrksich, Milan https://orcid.org/0000-0002-4964-796X
DeLisa, Matthew P. https://orcid.org/0000-0003-3226-1566
Jewett, Michael C. https://orcid.org/0000-0003-2948-6211
-
Funding
Funding for this research was provided by:
National Science Foundation (DGE-1324585, MCB-1413563, MCB-1413563, NSF ECCS-1542205)
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-10052/P00001, HDTRA1-15-10052/P00001, HDTRA1-15-10052/P00001)
David and Lucile Packard Foundation
Camille and Henry Dreyfus Foundation
- License Information
-
More Information
Article History
Received: 13 January 2019
Accepted: 15 August 2019
First Online: 27 November 2019
Competing interests
: M.P.D. has a financial interest in Glycobia, Inc., Versatope, Inc., and SwiftScale Biologics. M.P.D.’s interests are reviewed and managed by Cornell University in accordance with their conflict of interest policies. M.C.J. has a financial interest in SwiftScale Biologics. M.C.J.’s interests are reviewed and managed by Northwestern University in accordance with their conflict of interest policies. All other authors declare no competing interests.
